{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T01:34:32Z","timestamp":1792114472408,"version":"4.4.0"},"reference-count":17,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,2,2]],"date-time":"2022-02-02T00:00:00Z","timestamp":1643760000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,2,2]],"date-time":"2022-02-02T00:00:00Z","timestamp":1643760000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Ophthalmol"],"published-print":{"date-parts":[[2022,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Human herpesvirus 6B (HHV-6B) is known to cause exanthema subitem and has been detected in various ocular diseases, including keratitis, uveitis, optic neuritis, and endophthalmitis; however, the long-term outcome after the reactivation of HHV-6B has not been well-addressed. Sugita et al. previously reported the concomitant presence of HHV-6B with herpes simplex virus-1 (HSV-1) in the aqueous fluid at the onset of corneal endotheliitis. We focused on the same patient with corneal endotheliitis, in whom both HSV-1 and HHV-6B sequences were observed, and reported the clinical course and long-term outcomes.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Case presentation<\/jats:title>\n                <jats:p>A 64-year-old woman was referred to our center for visual disturbances in the left eye. Her best-corrected visual acuity in the left eye was 0.5 and the left intraocular pressure was elevated to 33\u2009mmHg. Mid-sized keratic precipitates and 2+ cells were observed in the anterior chamber with corneal endothelial edema and reduction of the corneal endothelial cell density to 1828 cells\/mm<jats:sup>2<\/jats:sup>. The patient was diagnosed with corneal endotheliitis with increased intraocular pressure. Polymerase chain reaction analysis revealed the concomitant presence of both HSV-1 and HHV-6B sequences in the left aqueous fluid. After treatment with oral valacyclovir and topical betamethasone, her intraocular inflammation gradually improved and has not recurred at 12\u2009years after corneal endotheliitis onset although corneal opacity remained.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>Reactivation of HHV-6B infection might be associated with HSV-1 corneal endotheliitis; however, no serious late sequelae occurred after appropriate treatment for HSV-1 infection in this immunocompetent host.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12886-022-02274-5","type":"journal-article","created":{"date-parts":[[2022,2,2]],"date-time":"2022-02-02T01:02:40Z","timestamp":1643763760000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Long-term outcome in corneal endotheliitis with molecular detection of herpes simplex virus 1 and human herpes virus 6: a case report"],"prefix":"10.1186","volume":"22","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1288-2798","authenticated-orcid":false,"given":"Takashi","family":"Ono","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takuya","family":"Iwasaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yukiko","family":"Terada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yosai","family":"Mori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryohei","family":"Nejima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mineo","family":"Ozaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manabu","family":"Mochizuki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazunori","family":"Miyata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,2,2]]},"reference":[{"key":"2274_CR1","doi-asserted-by":"publisher","first-page":"596","DOI":"10.1126\/science.2876520","volume":"234","author":"SZ Salahuddin","year":"1986","unstructured":"Salahuddin SZ, Ablashi DV, Markham PD, Josephs SF, Sturzenegger S, Kaplan M, et al. Isolation of a new virus, HBLV, in patients with lymphoproliferative disorders. Science. 1986;234:596\u2013601.","journal-title":"Science."},{"key":"2274_CR2","doi-asserted-by":"publisher","first-page":"863","DOI":"10.1007\/s00705-013-1902-5","volume":"159","author":"D Ablashi","year":"2014","unstructured":"Ablashi D, Agut H, Alvarez-Lafuente R, Clark DA, Dewhurst S, DiLuca D, et al. Classification of HHV-6a and HHV-6B as distinct viruses. Arch Virol. 2014;159:863\u201370.","journal-title":"Arch Virol"},{"key":"2274_CR3","doi-asserted-by":"publisher","first-page":"817","DOI":"10.1016\/S0092-8674(00)81678-5","volume":"99","author":"F Santoro","year":"1999","unstructured":"Santoro F, Kennedy PE, Locatelli G, Malnati MS, Berger EA, Lusso P. CD46 is a cellular receptor for human herpesvirus 6. Cell. 1999;99:817\u201327.","journal-title":"Cell."},{"key":"2274_CR4","doi-asserted-by":"publisher","first-page":"9096","DOI":"10.1073\/pnas.1305187110","volume":"110","author":"H Tang","year":"2013","unstructured":"Tang H, Serada S, Kawabata A, Ota M, Hayashi E, Naka T, et al. CD134 is a cellular receptor specific for human herpesvirus-6B entry. Proc Natl Acad Sci U S A. 2013;110:9096\u20139.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2274_CR5","doi-asserted-by":"publisher","first-page":"1065","DOI":"10.1016\/S0140-6736(88)91893-4","volume":"1","author":"K Yamanishi","year":"1988","unstructured":"Yamanishi K, Okuno T, Shiraki K, Takahashi M, Kondo T, Asano Y, et al. Identification of human herpesvirus-6 as a causal agent for exanthem subitum. Lancet. 1988;1:1065\u20137.","journal-title":"Lancet."},{"key":"2274_CR6","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1128\/jcm.27.4.651-653.1989","volume":"27","author":"T Okuno","year":"1989","unstructured":"Okuno T, Takahashi K, Balachandra K, Shiraki K, Yamanishi K, Takahashi M, et al. Seroepidemilogy of huma herpesvirus 6 infection in normal children and adults. J Clin Microbiol. 1989;27:651\u20133.","journal-title":"J Clin Microbiol"},{"key":"2274_CR7","doi-asserted-by":"publisher","first-page":"e942","DOI":"10.1212\/NXI.0000000000000942","volume":"8","author":"G Berzero","year":"2021","unstructured":"Berzero G, Campanini G, Vegezzi E, Paoletti M, Pichiecchio A, Simoncelli AM, et al. Human herpesvirus 6 encephalitis in immunocompetent and immunocompromised hosts. Neurol Neuroimmunol Neuroinflamm. 2021;8:e942.","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"2274_CR8","doi-asserted-by":"publisher","first-page":"1108","DOI":"10.1001\/archderm.134.9.1108","volume":"134","author":"Y Suzuki","year":"1998","unstructured":"Suzuki Y, Inagi R, Aono T, Yamanishi K, Shiohara T. Human herpesvirus 6 infection as a risk factor for the development of severe drug-induced hypersensitivity syndrome. Arch Dermatol. 1998;134:1108\u201312.","journal-title":"Arch Dermatol"},{"key":"2274_CR9","doi-asserted-by":"publisher","first-page":"1113","DOI":"10.1001\/archderm.134.9.1113","volume":"134","author":"M Tohyama","year":"1998","unstructured":"Tohyama M, Yahata Y, Yasukawa M, Inagi R, Urano Y, Yamanishi K, et al. Severe hypersensitivity syndrome due to sulfasalazine associated with reactivation of human herpesvirus 6. Arch Dermatol. 1998;134:1113\u20137.","journal-title":"Arch Dermatol"},{"key":"2274_CR10","doi-asserted-by":"publisher","first-page":"4692","DOI":"10.1167\/iovs.12-10095","volume":"53","author":"S Sugita","year":"2012","unstructured":"Sugita S, Shimizu N, Watanabe K, Ogawa M, Maruyama K, Usui N, et al. Virological analysis in patients with human herpes virus 6-associated ocular inflammatory disorders. Invest Ophthalmol Vis Sci. 2012;53:4692\u20138.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"2274_CR11","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1080\/08820530802111010","volume":"23","author":"T Suzuki","year":"2008","unstructured":"Suzuki T, Ohashi Y. Corneal endotheliitis. Semin Ophthalmol. 2008;23:235\u201340.","journal-title":"Semin Ophthalmol"},{"key":"2274_CR12","doi-asserted-by":"publisher","first-page":"S3","DOI":"10.1097\/ICO.0000000000000228","volume":"33","author":"Y Inoue","year":"2014","unstructured":"Inoue Y. Review of clinical and basic approaches to corneal endotheliitis. Cornea. 2014;33:S3\u20138.","journal-title":"Cornea."},{"key":"2274_CR13","doi-asserted-by":"publisher","first-page":"2785","DOI":"10.1007\/s10792-019-01125-5","volume":"39","author":"JI Sakai","year":"2019","unstructured":"Sakai JI, Usui Y, Suzuki J, Kezuka T, Goto H. Clinical features of anterior uveitis caused by three different herpes viruses. Int Ophthalmol. 2019;39:2785\u201395.","journal-title":"Int Ophthalmol"},{"key":"2274_CR14","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1016\/j.ajo.2019.10.031","volume":"213","author":"S Nakano","year":"2020","unstructured":"Nakano S, Tomaru Y, Kubota T, Takase H, Mochizuki M, Shimizu N, et al. Evaluation of a multiplex strip PCR test for infectious uveitis: a prospective multicenter study. Am J Ophthalmol. 2020;213:252\u20139.","journal-title":"Am J Ophthalmol"},{"key":"2274_CR15","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1097\/ICB.0b013e3182595705","volume":"7","author":"P Malamos","year":"2013","unstructured":"Malamos P, Maselos S, Andrianopoulos K, Georgalas I, Chryssos G, Markomichelakis NN. Human herpes virus-6 as a cause of recurrent posterior uveitis in a HIV-positive patient. Retin Cases Brief Rep. 2013;7:131\u20133.","journal-title":"Retin Cases Brief Rep"},{"key":"2274_CR16","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1186\/s12348-014-0016-x","volume":"4","author":"J Bajric","year":"2014","unstructured":"Bajric J, Smith WM. A case of bilateral human herpes virus 6 panuveitis with genomic viral DNA integration. J Ophthal Inflam Infect. 2014;4:16.","journal-title":"J Ophthal Inflam Infect"},{"key":"2274_CR17","first-page":"e237","volume":"54","author":"J Maslin","year":"2007","unstructured":"Maslin J, Bigaillon C, Froussard F, Enouf V, Nicand E. Acute bilateral uveitis associated with an active human herpesvirus-6 infection. J Inf Secur. 2007;54:e237\u201340.","journal-title":"J Inf Secur"}],"container-title":["BMC Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12886-022-02274-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12886-022-02274-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12886-022-02274-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,2,2]],"date-time":"2022-02-02T01:03:35Z","timestamp":1643763815000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcophthalmol.biomedcentral.com\/articles\/10.1186\/s12886-022-02274-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,2,2]]},"references-count":17,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["2274"],"URL":"https:\/\/doi.org\/10.1186\/s12886-022-02274-5","relation":{},"ISSN":["1471-2415"],"issn-type":[{"value":"1471-2415","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,2,2]]},"assertion":[{"value":"27 May 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 January 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 February 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This clinical study adhered to the tenets of the Declaration of Helsinki.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Written informed consent was obtained from the patient for the publication of this report.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"48"}}